Search
for
Sort by
Research 211–240 of 1000+
- State-dependent signaling by Ca<sub>v</sub>1.2 regulates hair follicle stem cell function
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- 5alpha-reductase 2 inhibition impairs brain defeminization of male rats: Reproductive aspects
- The first clinical trial of topical application of procyanidin B‐2 to investigate its potential as a hair growing agent
- The Pharmacokinetics of 2.5- to 10-mg Oral Doses of Minoxidil in Healthy Volunteers
- Acute telogen effluvium associated with SARS-CoV-2 infection
- Hair regrowth in 2 patients with recalcitrant central centrifugal cicatricial alopecia after use of topical metformin
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- Melanocortin receptor type 2 (MC2R, ACTH receptor) expression in patients with alopecia areata
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors
- Pmg-1 and Pmg-2 constitute a novel family of KAP genes differentially expressed during skin and mammary gland development
- Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles
- Re-epithelialization of the skin following CO 2 laser resurfacing
- The role of ketoconazole 2% shampoo in the treatment and prophylactic management of dandruff
- Molecular interactions of progesterone derivatives with 5α-reductase types 1 and 2 and androgen receptors
- Expression patterns of the glial cell line–derived neurotrophic factor, neurturin, their cognate receptors GFRα-1, GFRα-2, and a common signal transduction element c-Ret in the human skin hair follicles
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors
- Minoxidil induced hypertrichosis in a 2 year-old child
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss
- Genetic association of complement component 2 polymorphism with systemic lupus erythematosus
- Preparation of 4-aryl-2-trifluoromethylbenzonitrile derivatives as androgen receptor antagonists for topical suppression of sebum production
- Finasteride-Induced Inhibition of 5α-Reductase Type 2 Could Lead to Kidney Damage—Animal, Experimental Study
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Diagnosis of Trichothiodystrophy in 2 Siblings
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- Nuclear factor (erythroid-derived 2)-like-2 pathway modulates substance P–induced human mast cell activation and degranulation in the hair follicle
- Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2
- Autoimmune polyglandular syndrome type 2, alopecia universalis and Crohn's disease